体细胞超增强子重复与热点突变驱动KLF5转录因子致癌激活
该研究报道KLF5在多种癌症中通过三种不同机制被体细胞基因组改变激活:鳞癌中超增强子局部扩增上调KLF5表达,结直肠癌中错义突变破坏KLF5-FBXW7互作提高蛋白稳定性,以及锌指DNA结合域内癌症类型特异性热点突变改变DNA结合特异性并重塑转录。CRISPR/Cas9敲除筛选显示KLF5过表达的癌细胞依赖KLF5增殖,提示KLF5为潜在治疗靶点。
要点
- 鳞癌中超增强子局部扩增激活KLF5表达。
- 结直肠癌错义突变破坏KLF5-FBXW7互作增加KLF5蛋白稳定性。
- KLF5过表达癌细胞依赖KLF5增殖,提示其为潜在靶点。
核心结论
- KLF5通过超增强子扩增、错义突变和热点突变三种机制被体细胞基因组改变致癌性激活。
- KLF5过表达的癌细胞依赖KLF5增殖,提示KLF5为潜在治疗靶点。
研究设计与样本
- 基于CRISPR/Cas9基因敲除筛选数据的功能研究。
- 分析多种癌症类型中KLF5的体细胞编码与非编码基因组改变。
主要发现
- 鳞状细胞癌中超增强子局部扩增激活KLF5表达。
- 结直肠癌中错义突变破坏KLF5-FBXW7互作,增加KLF5蛋白稳定性。
- KLF5锌指DNA结合域内癌症类型特异性热点突变改变其DNA结合特异性并重塑细胞转录。
- CRISPR/Cas9敲除筛选显示KLF5过表达的癌细胞依赖KLF5进行增殖。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Krüppel-like family of transcription factors plays critical roles in human development and is associated with cancer pathogenesis. Krüppel-like factor 5 gene (KLF5) has been shown to promote cancer cell proliferation and tumorigenesis and to be genomically amplified in cancer cells. We recently reported that the KLF5 gene is also subject to other types of somatic coding and noncoding genomic alterations in diverse cancer types. Here, we show that these alterations activate KLF5 by three distinct mechanisms: (i) Focal amplification of superenhancers activates KLF5 expression in squamous cell carcinomas; (ii) Missense mutations disrupt KLF5-FBXW7 interactions to increase KLF5 protein stability in colorectal cancer; (iii) Cancer type-specific hotspot mutations within a zinc-finger DNA binding domain of KLF5 change its DNA binding specificity and reshape cellular transcription. Utilizing data from CRISPR/Cas9 gene knockout screening, we reveal that cancer cells with KLF5 overexpression are dependent on KLF5 for their proliferation, suggesting KLF5 as a putative therapeutic target.Significance: Our observations, together with previous studies that identified oncogenic properties of KLF5, establish the importance of KLF5 activation in human cancers, delineate the varied genomic mechanisms underlying this occurrence, and nominate KLF5 as a putative target for therapeutic intervention in cancer. Cancer Discov; 8(1); 108-25. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 1.
引用
- Zhang X, Choi PS, Francis JM, et al. Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor. Cancer Discov. 2017. PMID: 28963353. doi:10.1158/2159-8290.CD-17-0532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。